Llegó la temporada de las cefaleas en brotes
Mayo ClinicLas cefaleas en brotes no son tan comunes, pero sí extremadamente dolorosas. Y suelen aparecer con el cambio de estación.
Las cefaleas en brotes no son tan comunes, pero sí extremadamente dolorosas. Y suelen aparecer con el cambio de estación.
The largest brain autopsy study of women who had experienced intimate partner violence reveals substantial vascular and white matter damage in the brain, but no evidence of chronic traumatic encephalopathy (CTE), the neurodegenerative disease recognized among male contact sports athletes who sustain repeated head trauma.
Building upon the expertise in dementia research and care across Penn Medicine, the health system has been awarded a $5 million grant from the Delaware Community Foundation to support the Penn Institute on Aging’s (IOA) work to develop the next generation of therapies for Alzheimer’s disease and related dementias (ADRD).
Investigators have developed a new risk score that assesses a person’s risk for developing ALS, as well as for survival after diagnosis, using a blood sample based on exposure to toxins in the environment, a new study shows.
Previously, touch was thought to be detected only by nerve endings present within the skin and surrounding hair follicles.
The rise of the capabilities of artificial intelligence (AI) systems has led to the view that these systems might soon be conscious. However, we might underestimate the neurobiological mechanisms underlying human consciousness.
A research team from the Monell Chemical Senses Center demonstrated, using a novel quantitative analysis, that the neuronal response to odors undergoes some modifications in the nose. Such early processing of olfactory signals is a result of interactions between olfactory receptor neurons and the neighboring trigeminal neurons.
Up to 1.7 million people could be living with dementia in England and Wales by 2040 – over 40% more than previously forecast – finds a new UCL-led study.
Marissa Scavuzzo, a postdoctoral fellow at the Case Western Reserve University School of Medicine, has won the 2023 Eppendorf & Science Prize for Neurobiology for research in how glial cells in the intestine’s nervous system operate.
A new research study shows that cerebrospinal fluid reduces current treatment efficacy in brain cancer and identifies new therapeutic opportunities.
When Yale neuroscientist Joy Hirsch used sophisticated imaging tools to track in real time the brain activity of two people engaged in conversation, she discovered an intricate choreography of neural activity in areas of the brain that govern social interactions.
To help ensure that patients with active substance use disorder, on medication-assisted treatment, or in abstinent recovery continue to receive high-quality, safe pain management and anesthesia care, the American Association of Nurse Anesthesiology (AANA) has published its updated analgesia and anesthesia practice considerations.
Older people who have higher levels of triglycerides, a type of fat, may have a lower risk of dementia and a slower cognitive decline over time compared to people who have lower levels, according to new research published in the October 25, 2023, online issue of Neurology®, the medical journal of the American Academy of Neurology.
People who have experienced traumatic events in childhood such as abuse, neglect or household dysfunction may be more likely to experience headache disorders as adults, according to a meta-analysis published in the October 25, 2023, online issue of Neurology®, the medical journal of the American Academy of Neurology. This research does not prove that such experiences cause headaches; it only shows an association.
How do our brains take in complex information from the world around us to help us make decisions? And what happens when there’s a mismatch between how well your brain thinks it’s performing this function and how well it’s actually doing? In this episode of the UCI School of Social Sciences Experts On, cognitive scientist Megan Peters takes a deep dive into metacognition - our ability to monitor our own cognitive processing.
Researchers found that listening to our preferred music reduces pain intensity and unpleasantness, knowledge which could optimize music-based pain therapies
Post COVID-19 condition does not appear to be linked to direct viral invasion of the brain or active brain damage. This has been shown by a study at the University of Gothenburg. Searching for abnormal biomarkers among the participants yielded no hits in either blood or cerebrospinal fluid samples
This cutting-edge technique activates a specific neurotransmitter receptor using mid-infrared light, which can penetrate deep into tissue and offers unparalleled pharmacological and spatiotemporal precision in three dimensions.
In a mouse study designed to explore the impact of marijuana’s major psychoactive compound, THC, on teenage brains, Johns Hopkins Medicine researchers say they found changes to the structure of microglia, which are specialized brain immune cells, that may worsen a genetic predisposition to schizophrenia. The
Rutgers researchers find long-term users of cocaine may continue with unrewarding behavior because of changes in brain structure and chemistry responsible for generating an important teaching signal.
A Mount Sinai-led team of researchers has shed new light on the ways in which cocaine addiction dysregulates the normal function of dopamine neurons and thus the brain’s ability to process and respond to reward-related information, making it more difficult for individuals to change their addictive behaviors.
Tim Evans is participating in a clinical trial at Johns Hopkins Medicine, in collaboration with the Johns Hopkins University Applied Physics Laboratory, that is looking at a series of studies using the device in patients with severe speech and movement difficulties to regain some of the abilities lost due to neurological diseases.
Oct. Tipsheet - Sylvester’s top leader receives prestigious award, a pioneering physician is elected to the Neuro-Oncology Society’s board, an NCI grant funds research into lifestyle interventions for breast cancer patients, breast cancer and stress, teaming up with the Dolphins to battle breast cancer, physician burnout, more.
Schizophrenia is a severe neuropsychiatric disease that remains poorly understood and treated. Schizophrenia onset is typically in adolescence or early adulthood, but its underlying causes are thought to involve neurodevelopmental abnormalities.
Curiosity paradoxically increases people’s patience for an answer, while simultaneously making them more eager to hear it, finds a new study by Duke neuroscientists.
The Hackensack Meridian Neuroscience Institute at Jersey Shore University Medical Center recently added the new Siemens Healthineers ARTIS icono biplane system to its interventional imaging services thanks to an extraordinarily generous gift from Mrs. Mary Ellen Harris and the Golden Dome Foundation.
Read the latest research news on air pollution, nanoplastics, waterborne illnesses and more in the Pollution channel on Newswise.
Huda Akil, Ph.D., a neuroscientist who has explored the brain’s secrets for more than 50 years, delving deep into the genes, proteins and cells that help govern our emotions and moods, and our responses to pleasure and pain, has received the nation’s highest scientific honor – the National Medal of Science.
In a new case report, researchers at UCLA Health describe promising results using repetitive transcranial magnetic stimulation (rTMS) in the management of post-stroke cerebellar ataxia, a debilitating condition marked by impaired coordination and balance.
This smartphone attachment could enable people to screen for a variety of neurological conditions, such as Alzheimer’s disease and traumatic brain injury, at low cost—and do so accurately regardless of their skin tone.
Two different regions of the brain are critical to integrating semantic information while reading, which could shed more light on why people with aphasia have difficulty with semantics, according to new research from UTHealth Houston.
A $3.6 million award from the National Institutes of Health will allow neurosurgical, neurology and neuroscience researchers at The Ohio State University Wexner Medical Center and College of Medicine to test a novel diagnosis and treatment combination for painful diabetic neuropathy.
World Stroke Day stories ahead of World Stroke Day on October 29th
For the first time, a Cornell University-led study in rats teases apart the role of the hippocampus in two functions of memory – one that remembers associations between time, place and what one did, and another that allows one to predict or plan future actions based on past experiences.
A team of researchers describes in Nature Cell Biology the mechanism by which the MEC-2 protein condensates of the touch receptor neurons transition from fluid to solid-like states, switching their role in the transmission of mechanical forces. These findings pave the way for developing innovative therapies and treatments.
Ten years after the creation of Rutgers Biomedical and Health Sciences, new university institutes and centers are bringing the world’s best medical ideas to New Jersey and beyond
New findings from researchers at UCLA Health suggest that measuring changes in how pupils react to light could help predict recovery from depression and personalize transcranial magnetic stimulation (TMS) treatment of major depressive disorder.
This special edition features upcoming oral presentations by MD Anderson researchers at the 2023 European Society for Medical Oncology (ESMO) Congress focused on clinical advances across a variety of cancer types.
How the mind searches for words and concepts in memory may have its origins in age-old patterns by which human and nonhuman animals search for food and other resources in their physical environment.
Researchers at Kyushu University have discovered that turning brain immune cells into neurons successfully restores brain function after stroke-like injury in mice. These findings, published on October 10 in PNAS, suggest that replenishing neurons from immune cells could be a promising avenue for treating stroke in humans.
Having a COVID-19 infection is associated with an increased risk of developing the rare disorder called Guillain-Barré syndrome within the next six weeks, according to a study published in the October 18, 2023, online issue of Neurology®, the medical journal of the American Academy of Neurology. The study also found that people who received the mRNA vaccine from Pfizer-BioNTech were less likely to develop the disorder in the next six weeks than people who did not receive the mRNA vaccine.
Researchers propose a novel approach that utilizes deep learning to generate three-dimensional holograms from colored two-dimensional images
A team from the Vehicle Safety Institute at TU Graz has used Human Body Models to investigate accidents involving electric scooters and identified the most important factors for preventing serious injuries
The collaboration includes multiple components aimed at bringing together Ochsner’s clinical services and innovation capabilities and Team Gleason’s innovative care solutions and other support services to provide ALS patients with continued purpose and independence.
Sleeping patterns and stress hormones could be the key to understanding how and when people with epilepsy are likely to experience seizures, a new study reveals.
The Gore RELIEF Clinical Study is evaluating the safety and efficacy of transcatheter closure of patent foramen ovale (PFO) with the GORE® CARDIOFORM Septal Occluder for the relief of migraine headaches.
The link between high blood pressure and a range of health problems is well known, and Australian researchers have now found that fluctuating blood pressure can be just as risky and a potential precursor to dementia and vascular disease.
Human sensory systems are very good at recognizing objects that we see or words that we hear, even if the object is upside down or the word is spoken by a voice we’ve never heard.
Life expectancy has increased substantially for people in the United States with Down syndrome, from a median age of 4 years old in the 1950s to 57 years old in 2019.